Keyphrases
Diagnostic Applications
100%
Related Disorders
100%
Novel Diagnostics
100%
Disease-associated
100%
Immunoassay
60%
Parkinson's Disease
50%
Neurodegenerative Diseases
50%
Amplification Assay
40%
Multiple System Atrophy
40%
Cerebrospinal Fluid
40%
Parkinson's Disease Dementia
40%
Dementia with Lewy Bodies
40%
Body Systems
40%
Real-time Quaking-induced Conversion (RT-QuIC)
20%
Human Cerebrospinal Fluid
20%
Parkinson's Disease Progression
20%
Plasma Samples
20%
Protein Aggregates
20%
Pathological Features
20%
High Sensitivity
20%
Primary Barrier
20%
Control Subjects
20%
Cerebrospinal Fluid Samples
20%
Glia
20%
Parkinson's Disease Diagnosis
20%
Preclinical Stage
20%
Biofluids
20%
Specificity Protein 1
20%
Invasive Procedures
20%
Clinical Symptoms
20%
Beta Sheet
20%
Longitudinal Cohort Study
20%
Clinical Profile
20%
Clinical Onset
20%
Amplification Method
20%
Cross-sectional Cohort Study
20%
Novel Antibodies
20%
β-sheet Structure
20%
Less Invasive
20%
Healthy Controls
20%
Alpha-synuclein (α-syn)
10%
Khalifa
10%
Disease Control
10%
Therapeutic Target
10%
Medicine and Dentistry
Parkinson's Disease
100%
Cerebrospinal Fluid
50%
Degenerative Disease
50%
Disease
50%
Diagnosis
50%
Beta Sheet
33%
Diffuse Lewy Body Disease
33%
Shy-Drager Syndrome
33%
Immunoassay
25%
Glia
16%
Synuclein
16%
Sensitivity and Specificity
16%
Monoclonal Antibody
16%
Protein Aggregate
16%
Biological Marker
16%
Cohort Analysis
8%
Symptom
8%
Disease Exacerbation
8%
Enzyme Linked Immunosorbent Assay
8%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
50%
Disease
50%
Degenerative Disease
42%
Diffuse Lewy Body Disease
28%
Shy Drager Syndrome
28%
Immunoassay
21%
Biological Marker
14%
Protein Aggregate
14%
Cohort Study
14%
Monoclonal Antibody
14%
Synuclein
7%
Enzyme-Linked Immunosorbent Assay
7%
Symptom
7%